Sigyn Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Market Capitalization	7	5	254	728	376	13	26	226	5	1,373	1,118
Market Cap Growth	-	-97.95%	-65.07%	93.40%	2794.33%	-50.04%	-88.49%	4633.56%	-99.65%	22.79%	-
Enterprise Value	10	8	256	729	377	15	28	227	5	1,372	1,118
PE Ratio	-1.26	-1.26	-68.51	-213.87	-234.84	-4.15	-9.93	-53.17	-5.74	-509.56	-2885.01
PS Ratio	-	-	-	-	-	90.73	918.20	176.02	2.65	47006.45	25908.79
PB Ratio	-1.73	-1.53	-133.61	-2751.23	3795.01	-5.28	-7.01	-107.96	-6.90	-16741.26	11244.44
P/FCF Ratio	-4.27	-3.76	-138.88	-403.63	-447.75	-90.51	-88.37	-471.84	-19.16	-14260.96	-23339.28
P/OCF Ratio	-4.27	-3.76	-138.94	-410.29	-453.58	-90.51	-90.98	-565.11	-36.44	-16379.35	-25159.05
EV/Sales Ratio	-	-	-	-	-	103.99	982.68	176.98	2.91	46985.01	25908.79
EV/EBITDA Ratio	-3.39	-3.10	-112.72	-355.32	-416.31	-33.67	-36.78	-103.37	-8.41	-609.37	-2885.01
EV/EBIT Ratio	-3.38	-3.09	-112.20	-352.03	-411.18	-28.77	-27.73	-93.36	-7.39	-609.06	-
EV/FCF Ratio	-6.00	-5.49	-139.90	-403.96	-448.27	-103.72	-94.57	-474.39	-21.05	-14254.46	-23339.28
Debt / Equity Ratio	-0.70	-0.70	-0.99	-3.53	5.23	-0.77	-0.49	-0.59	-0.90	-0.15	0
Debt / EBITDA Ratio	-0.98	-0.98	-0.83	-0.46	-0.57	-4.29	-2.42	-0.56	-0.99	-0.01	-
Debt / FCF Ratio	-1.73	-1.73	-1.03	-0.52	-0.62	-13.22	-6.23	-2.57	-2.49	-0.13	-
Quick Ratio	0.00	0.00	0.00	0.46	0.14	0.00	0.00	0.00	0.05	0.43	0.02
Current Ratio	0.03	0.03	0.03	0.54	1.13	0.19	0.16	0.18	0.29	0.78	1.05
Asset Turnover	0	0	0	0	0	0.22	0.03	0.62	0.77	0.02	0.08
Interest Coverage	-1.23	-1.20	-3.32	-5.03	-2.67	-9.38	-2.85	-3.08	-13.46	-5.11	0
Return on Equity (ROE)	145.48%	121.49%	195.03%	1286.43%	-1616.01%	127.20%	70.53%	203.03%	120.19%	3285.42%	-389.75%
Return on Assets (ROA)	-1542.72%	-1288.33%	-1115.10%	-479.22%	-230.92%	-487.41%	-303.96%	-205.27%	-35.50%	-188.81%	-68.93%
Return on Capital (ROIC)	241.96%	241.96%	8271.76%	-300.03%	-148.33%	92.33%	53.44%	282.33%	980.72%	3245.79%	-389.75%
Earnings Yield	-67.01%	-79.66%	-1.46%	-0.47%	-0.43%	-24.07%	-10.07%	-1.88%	-17.41%	-0.20%	-0.03%
FCF Yield	-18.67%	-26.58%	-0.72%	-0.25%	-0.22%	-1.10%	-1.13%	-0.21%	-5.22%	-0.01%	-0.00%
Buyback Yield / Dilution	96.66%	97.06%	-2.75%	-395.11%	-1256.72%	-24.90%	-38.17%	-4239.14%	96.84%	-22.79%	-
Total Shareholder Return	96.66%	97.06%	-2.75%	-395.11%	-1256.72%	-24.90%	-38.17%	-4239.14%	96.84%	-22.79%	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.